TOP STORIES

• BUSINESS Gilead Mulling Japan Entry into PIII Study for Inhaled Version of Veklury
  February 5, 2021

• BUSINESS Drug Makers Moving to Discontinue Ranitidine/Nizatidine Products over Carcinogen Issue
  February 4, 2021

• REGULATORY Celgene’s Liso-Cel Up for PAFSC Review on Feb. 17, 3rd CAR-T Therapy in Japan
  February 4, 2021

• BUSINESS Eisai Neurology Chief Says Partners Continue to Stand Behind Aducanumab
  February 4, 2021

• ORGANIZATION PhRMA Prods Japan to Harness Power of RWD in Drug Development, Medical Care Evaluation
  February 3, 2021

• REGULATORY Japan Moves Up Vaccine Rollout Target to Mid-February, PAFSC Review on Feb. 12?
  February 3, 2021

• INTERVIEW Alzheimer’s Treatment at Crossroads? Top Expert on AD Research, Aducanumab and Its Implications - 1
  February 2, 2021

• BUSINESS Teijin to Acquire Fujifilm's J-TEC for Up to 21.6 Billion Yen
  February 1, 2021

• BUSINESS FDA Delays Decision for Biogen’s Aducanumab to June 7
  February 1, 2021

• REGULATORY MHLW Wants to Encourage Non-Monitoring Facilities to Report Inappropriate Drug Promotion
  January 29, 2021

• BUSINESS Kobayashi Kako Issues Yet Another Recall, Now for 12 APIs/21 Products
  January 28, 2021

• REGULATORY Kobayashi Kako Might Face 116-Day Biz Suspension over Drug Mix-Up
  January 27, 2021

• REGULATORY Kobayashi Kako Notified of Record Biz Suspension of 110-Plus Days over Drug Mix-Up
  January 26, 2021

• REGULATORY MHLW Approves Sakigake-Designated HAE Treatment, Lilly’s Migraine Med, Takeda’s Alunbrig, Ono’s Cachexia Drug, and More
  January 25, 2021

• BUSINESS Genmab Poised to Triple Japan Staff for Stand-Alone Biz, First Up Is ADC for Cervical Cancer
  January 22, 2021

• BUSINESS Moderna’s COVID-19 Shot Enters Clinical Trial in Japan: Takeda
  January 21, 2021

• REGULATORY Kobayashi Kako Submits Report on Drug Mix-Up, Could Face Administrative Penalty in 1st Half of February
  January 21, 2021

• REGULATORY Japan, Pfizer Finalize COVID-19 Vaccine Deal, Agree on Supply of 144 Million Doses
  January 21, 2021

• BUSINESS Will Cymbalta, E Keppra Face Generic Competition This Year? Vesicare, Aloxi Too?
  January 20, 2021

• REGULATORY MHLW Eyes 1st Revision of Drug Industry Vision in 8 Years as Off-Year Re-Pricing Takes Shape: Official
  January 19, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 100
• 101
• 102
• 103
• 104
• 105
• 106
• 107
• 108
• …
• Next ›
• 最終 »